Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization
Abstract
To cite this article: Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B, Stepankova R, Hudcovic T, Pollak A, Tlaskalova‐Hogenova H, Wiedermann U, Kozakova H. Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T‐regulatory responses upon systemic sensitization. Allergy 2011; 66: 368–375. Abstract Background: The use of recombinant lactic acid bacteria (LAB) as vehicles for mucosal delivery of recombinant allergens is an attractive concept for antigen‐defined allergy prevention/treatment. Interventions with LAB are of increasing interest early in life when immune programming is initiated. Here, we investigated the effect of neonatal colonization with a recombinant LAB producing the major birch pollen allergen Bet v 1 in a murine model of type I allergy. Methods: We constructed a recombinant Lactobacillus (L.) plantarum NCIMB8826 strain constitutively producing Bet v 1 to be used for natural mother‐to‐offspring mono‐colonization of germ‐free BALB/c mice. Allergen‐specific immunomodulatory effects of the colonization on humoral and cellular immune responses were investigated prior and after sensitization to Bet v 1. Results: Mono‐colonization with the Bet v 1 producing L. plantarum induced a Th1‐biased immune response at the cellular level, evident in IFN‐γ production of splenocytes upon stimulation with Bet v 1. After sensitization with Bet v 1 these mice displayed suppressed IL‐4 and IL‐5 production in spleen and mesenteric lymph node cell cultures as well as decreased allergen‐specific antibody responses (IgG1, IgG2a, and IgE) in sera. This suppression was associated with a significant up‐regulation of the regulatory marker Foxp3 at the mRNA level in the spleen cells. Conclusion: Intervention at birth with a live recombinant L. plantarum producing a clinically relevant allergen reduces experimental allergy and might therefore become an effective strategy for early intervention against the onset of allergic diseases.Keywords
This publication has 31 references indexed in Scilit:
- Development and Regulation of Immune Responses to Food Antigens in Pre- and Postnatal Life2009
- Allergy Therapy by Intranasal Administration with Recombinant Lactococcus lactis Producing Bovine β-LactoglobulinInternational Archives of Allergy and Immunology, 2009
- Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergyAllergy, 2009
- Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteriaNature Reviews Microbiology, 2008
- The European LABDEL project and its relevance to the prevention and treatment of allergiesAllergy, 2007
- In vivo and in vitro immunomodulation of Der p 1 allergen‐specific response by Lactobacillus plantarum bacteriaClinical & Experimental Allergy, 2007
- Constitutive Delivery of Bovine β-Lactoglobulin to the Digestive Tracts of Gnotobiotic Mice by EngineeredLactobacillus caseiApplied and Environmental Microbiology, 2006
- Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteriaVaccine, 2006
- Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1Allergy, 2006
- The role of Foxp3+ T cells in long‐term efficacy of prophylactic and therapeutic mucosal tolerance induction in miceAllergy, 2006